Uniper SE (0RJ4)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 43.68 |
|---|---|
| 52-week range | 27.25 – 56.10 |
| Return, 1 month / 3 months | −9.7% / −0.3% |
| Return, 1 year / 3 years | +40.0% / −45.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 38 |
| Volatility (1 year) | 44.4% |
| Worst drawdown (1 year) | -22.9% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Uniper SE is an energy company based in Düsseldorf, Germany. It operates power plants fired by gas, coal and other fuels, runs gas storage facilities, and trades gas and electricity in wholesale markets. Its customers include utilities, industrial companies and municipal suppliers across Europe. The company also provides energy trading and optimisation services, balancing supply and demand for its own generation fleet and for third parties, and it supplies gas to distributors and large consumers.
Uniper SE trades under the code 0RJ4 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Uniper SE (0RJ4) trades on the London Exchange in UK. It last closed at EUR 43.68 on 22 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 2,131 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.0% and over the last three months it fell 0.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.0% | ||
| From 52-week high | -18.2% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.3% | ||
| 6-month return | 5.4% | ||
| 12-month return, skipping the last month | 55.0% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.9% | ||
| Liquidity | 13 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 15 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | −9.7% |
| 3 months | −0.3% |
| 6 months | +5.4% |
| 1 year | +40.0% |
| 3 years | −45.1% |
| 5 years | −94.3% |
Signals
| 50-day / 200-day average | 46.41 / 41.98 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 May 2026 | EUR 0.7200 |
| 19 May 2022 | EUR 0.0700 |
| 20 May 2021 | EUR 1.3700 |
| 21 May 2020 | EUR 1.1500 |
| 23 May 2019 | EUR 0.9000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.